1. Home
  2. G vs INDV Comparison

G vs INDV Comparison

Compare G & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$28.28

Market Cap

5.4B

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$39.96

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
G
INDV
Founded
1997
N/A
Country
Bermuda
United States
Employees
140000
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.4B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
G
INDV
Price
$28.28
$39.96
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$49.50
N/A
AVG Volume (30 Days)
2.7M
1.6M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
2.21%
N/A
EPS Growth
9.82
8100.00
EPS
0.86
0.69
Revenue
$2,279,438,000.00
$1,239,000,000.00
Revenue This Year
$9.20
N/A
Revenue Next Year
$7.27
N/A
P/E Ratio
$32.69
$55.54
Revenue Growth
N/A
4.29
52 Week Low
$27.37
$13.47
52 Week High
$48.64
$41.00

Technical Indicators

Market Signals
Indicator
G
INDV
Relative Strength Index (RSI) 31.84 65.83
Support Level N/A $35.36
Resistance Level $35.09 $41.00
Average True Range (ATR) 1.08 1.28
MACD -0.39 0.12
Stochastic Oscillator 17.15 97.52

Price Performance

Historical Comparison
G
INDV

About G Genpact Limited

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: